Red Arrow Therapeutics Revenue and Competitors
Employee Data
- Red Arrow Therapeutics has 8 Employees.
- Red Arrow Therapeutics grew their employee count by -20% last year.
Red Arrow Therapeutics's People
| Name | Title | Email/Phone |
|---|
Red Arrow Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | N/A | 11 | 10% | N/A | N/A |
#10 | $5.4M | 35 | 3% | N/A | N/A |
What Is Red Arrow Therapeutics?
Red Arrow Therapeutics, Inc. is a biotechnology company focusing on developing new technologies that can turn \cold\ tumors into inflamed \hot\ tumors. Red Arrow Therapeutics' lead product candidate, RA-001, a pH-activated polymer micelle loaded with IL-12, is designed to release fully active IL-12 upon sensing intratumoral pH to safely potentiate immunotherapy. \nIn the current pre-clinical data, RA-001 exhibits strong anti-tumor immunity in various tumor models. Furthermore, RA-001 shows high efficacy as monotherapy and in combination with immune checkpoint inhibitors.
keywords:N/A
N/A
Total Funding
8
Number of Employees
N/A
Revenue (est)
-20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.8M | 8 | N/A | N/A |
#2 | $0.6M | 8 | 0% | N/A |
#3 | $0.6M | 8 | -33% | N/A |
#4 | $1.3M | 8 | -11% | N/A |
#5 | $2.1M | 8 | -43% | N/A |